Table of Content
Introduction
Procter & Gamble Hygiene & Health Care Ltd., a part of the Procter & Gamble Company (P&G), is a fast-moving consumer goods (FMCG) company based in India. The company develops and sells branded packaged FMCG products in the healthcare and feminine care sectors. Moreover, P&G Hygiene and Health Care Ltd. offers health care and hygiene products. The healthcare products segment includes various items, such as cough drops, tablets, and ointments and creams. On the other hand, the hygiene products segment includes feminine and skin care hygiene products. The company’s product portfolio comprises various best-selling items, including Vicks and Old Spice.
P&G Hygiene and Health Care announced its financial results for the quarter ending September 30, 2023, and reported a 36% YoY increase in its quarterly profit. Here are the essential facts and figures you must know.
Note: The company follows the July-June financial year.
Additional Read: Q2 Results Dashboard
Key Financial Metrics
Performance Highlights
- P&G Hygiene and Health Care reported a 36.44% rise in PAT at ₹210.69 Cr for Q1 FY24, compared to ₹154.41 during the same period last year.
- The company’s net sales were up by 9.04% YoY at ₹1,135.06 Cr versus ₹1,040.92 Cr reported during Q1 FY23.
- Its operational revenue for the period under review stood at ₹1,138.35 Cr, registering an 8.94% rise from ₹1,044.89 Cr in the corresponding period last year.
- The total income of the company jumped by 9.74% to ₹1,154.12 Cr during the period under review from ₹1,051.62 Cr during the same period last year.
P&G Hygiene and Health Care Limited also revealed that its total expenses went up by 2.81% YoY to ₹869.65 Cr, compared to ₹845.82 Cr in the corresponding period last year.
The company also said that the growth in PAT was driven by the acceleration of volume growth, product price mix, and productivity.
Also Read: Procter & Gamble Hygiene and Health Care Share Price
Procter & Gamble Hygiene & Health Care Limited: Financial Figures (QoQ)
| Particulars | Q1 FY 2023-24 | Q4 FY 2022-23 | Q1 FY 2022-23 |
| Revenue from Operations | ₹1,138.35 Cr | ₹852.53 Cr | ₹1,044.89 Cr |
| Total Income | ₹1,154.12 Cr | ₹862.63 Cr | ₹1,051.62 Cr |
| Total Expenses | ₹869.65 Cr | ₹656.05 Cr | ₹845.82 Cr |
| Profit Before Tax | ₹284.47 Cr | ₹206.58 Cr | ₹205.80 Cr |
| Profit for the Period | ₹210.69 Cr | ₹151.24 Cr | ₹154.41 Cr |
| Total Comprehensive Income | ₹208.82 Cr | ₹143.83 Cr | ₹155.77 Cr |
Also Read: FMCG Sector in India
Stock Performance
P&G Hygiene and Health Care declared its quarterly results on October 30th after the market hours. The company’s shares opened at ₹17,098.30 on Monday and declined 1.48%, eventually settling at ₹16,725 apiece on BSE.
About the Company
The Procter & Gamble Company (P&G), which owns the Procter & Gamble Hygiene & Health Care Ltd., was founded in 1837. The company offers various personal and consumer health products, along with personal care and hygiene products. These are further segregated into various segments, such as beauty, health care, and baby, feminine, and family care. Procter & Gamble Hygiene & Health Care Ltd. extends hygiene and health care products like feminine and skin care hygiene products and tablets. In 2016 and 2017, P&G was named one of Forbes World’s Most Reputable Companies.
Sources:
https://www.bseindia.com/xml-data/corpfiling/AttachLive/3b9e56ce-ee2d-4efc-921c-bfa34b7cacff.pdf
